aurabiosciences.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $225.08MM
Aura Biosciences is a biotechnology company developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed.
Company | Sector | IPO Date | IPO Price/Share | Price/Share as of 7/25/24 | Since IPO |
Aura Biosciences | Healthcare | 10/28/2021 | $14 | $10.27 | -26.6% |
Round Date | Series | Amount Raised | Post Money Valuation | Price/Share | Lead Investors | Since IPO |
3/21 | E | $80.4M | $283.0M | $0.78 | Matrix Capital Management, Surveyor Capital, Rock Springs Capital, Adage Capital Management LP, Velosity Capital, Medicxi, Advent Life Sciences, Lundbeckfonden Ventures, Arix Bioscience, Chiesi Ventures, Ysios Capital, Columbus Venture Partners | 1,216.7% |
7/20 | D-2 | $17.0M | $157.2M | $0.69 | Undisclosed Investors | 1,388.4% |
4/19 | D-1 | $39.9M | $139.5M | $0.69 | Medicxi, Advent Life Sciences, Arix Biosciences, Chiesi Ventures, Columbus Venture Partners, Lundekfonden Ventures, Ysios Capital | 1,388.4% |
12/17 | C-2 | $12.1M | $73.0M | $0.36 | Lundbeckfonden Ventures, Arix Biosciences, Advent Life Sciences, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments, Columbus Venture Partners, LI-COR Biosciences | 2,752.8% |
12/17 | C-1 | $30.2M | $73.0M | $0.52 | Lundbeckfonden Ventures, Arix Biosciences, Advent Life Sciences, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments, Columbus Venture Partners, LI-COR Biosciences | 1,875.0% |
3/15 | B | $28.2M | $50.2M | $1.24 | Advent Life Sciences, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments, LI-COR Biosciences | 728.2% |
8/14 | A-2 | $5.3M | $22.0M | $1.24 | Undisclosed Investors | 728.2% |
7/13 | A-1 | $8.1M | $29.1M | $2.48 | Undisclosed Investors | 314.1% |
8/11 | A | $3.4M | $16.0M | $2.00 | Undisclosed Investors | 413.5% |